Queen Mary University of London: Queen Mary professor receives prestigious Dentistry Gold Medal indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.
E-Mail
Alexandria, Va., USA - The International Association for Dental Research (IADR) announced David Williams, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK, as the 2021 recipient of the IADR Gold Medal Award. Williams was recognized during the Opening Ceremonies of the virtual 99th General Session & Exhibition of the IADR, held in conjunction with the 50th Annual Meeting of the American Association for Dental Research (AADR) and the 45th Annual Meeting of the Canadian Association for Dental Research (CADR), on July 21-24, 2021.
Williams is a Professor of Global Oral Health at Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. He is currently Co-Chair of the FDI World Dental Federation Vision 2030 Working Group, a member of the Advocacy Task Team, a member of the Oral Health Observatory Task Team and Chair of the Science Committee of the FDI. He is joint Chair of the project team, comprised of
David Williams named 2021 recipient of IADR Gold Medal Award miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Adequate reimbursement for molecular diagnostic tests can improve patient care
The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the results of its qualitative and quantitative Analysis of Professional Work Effort in Molecular Test Interpretation Report.
More than 100 molecular professionals from the AMP and American College of Medical Genetics and Genomics (ACMG) communities reported that their efforts spent on data analysis, interpretation, and reporting for molecular diagnostic tests were not sufficiently reimbursed.
Respondents indicated that adequate reimbursement for these activities would improve patient care by increasing access to these essential medical services and enabling more data-driven treatment decisions.